Home524816 • BOM
add
Natco Pharma Ltd.
Previous close
₹1,476.65
Day range
₹1,410.30 - ₹1,489.00
Year range
₹755.90 - ₹1,638.35
Market cap
254.14B INR
Avg Volume
51.08K
P/E ratio
13.07
Dividend yield
0.41%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 13.71B | 32.94% |
Operating expense | 4.35B | 8.42% |
Net income | 6.77B | 83.55% |
Net profit margin | 49.40 | 38.07% |
Earnings per share | 37.81 | 83.54% |
EBITDA | 8.03B | 75.44% |
Effective tax rate | 17.32% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.63B | 102.65% |
Total assets | 82.45B | 31.83% |
Total liabilities | 10.88B | 13.26% |
Total equity | 71.57B | — |
Shares outstanding | 179.13M | — |
Price to book | 3.70 | — |
Return on assets | — | — |
Return on capital | 27.91% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 6.77B | 83.55% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016
